Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-01901-0002-0000-5 |
Chemical Name: | Codeine phosphate |
CASRN: | 52-28-8 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 039151_CA |
Study Result: | Negative |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Negative |
Induced Rat Liver S9 | 1_S9 | Negative |
No Activation | 2 | Negative |
Induced Rat Liver S9 | 2_S9 | Negative |
No Activation | 3 | Negative |
No Activation | 4 | Test Failure |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
Test Chemical: | Codeine phosphate | 2500 | 100 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
3000 | 100 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | ||
3500 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.025 | 100 | 16 | 0.160 | 14.0 | 5 | 0.050 | 5.0 | 11 | 0.110 | 10.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.0625 | 25 | 6 | 0.240 | 24.0 | 1 | 0.040 | 4.0 | 4 | 0.160 | 16.0 | 1 | 0.040 | 4.0 | |
Trend: | -0.485 | -1.210 | 0.015 | ||||||||||||
Probability: | 0.686 | 0.887 | 0.494 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Medium | 0 | 100 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
Negative (Not Specified) | 0 | 100 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Codeine phosphate | 9000 | 100 | 4 | 0.040 | 4.0 | 0 | 0.000 | 0.0 | 4 | 0.040 | 4.0 | 0 | 0.000 | 0.0 |
9500 | 100 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | ||
10000 | 100 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 2.5 | 100 | 7 | 0.070 | 7.0 | 4 | 0.040 | 4.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 12.5 | 25 | 8 | 0.320 | 24.0 | 2 | 0.080 | 8.0 | 6 | 0.240 | 20.0 | 0 | 0.000 | 0.0 | |
Trend: | 0.684 | 1.334 | 0.289 | ||||||||||||
Probability: | 0.247 | 0.091 | 0.386 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 |
Medium | 0 | 100 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Codeine phosphate | 3500 | 100 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
4000 | 100 | 4 | 0.040 | 2.0 | 0 | 0.000 | 0.0 | 4 | 0.040 | 2.0 | 0 | 0.000 | 0.0 | ||
4500 | 100 | 4 | 0.040 | 4.0 | 2 | 0.020 | 2.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | ||
5000 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.025 | 100 | 9 | 0.090 | 9.0 | 3 | 0.030 | 3.0 | 6 | 0.060 | 6.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.0625 | 25 | 5 | 0.200 | 20.0 | 3 | 0.120 | 12.0 | 2 | 0.080 | 8.0 | 0 | 0.000 | 0.0 | |
Trend: | 0.248 | 1.263 | -0.449 | ||||||||||||
Probability: | 0.402 | 0.103 | 0.673 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
Medium | 0 | 100 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Codeine phosphate | 9000 | 100 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
9500 | 100 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | ||
10000 | 100 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 2.5 | 100 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 12.5 | 25 | 6 | 0.240 | 24.0 | 2 | 0.080 | 8.0 | 4 | 0.160 | 16.0 | 0 | 0.000 | 0.0 | |
Trend: | 0.610 | 0.624 | 0.275 | ||||||||||||
Probability: | 0.271 | 0.266 | 0.391 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Medium | 0 | 100 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
Negative (Not Specified) | 0 | 100 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Codeine phosphate | 2000 | 100 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 |
2500 | 100 | 4 | 0.040 | 4.0 | 2 | 0.020 | 2.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | ||
3000 | 100 | 4 | 0.040 | 3.0 | 0 | 0.000 | 0.0 | 4 | 0.040 | 3.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.0026 | 100 | 15 | 0.150 | 14.0 | 6 | 0.060 | 5.0 | 8 | 0.080 | 8.0 | 1 | 0.010 | 1.0 |
Mitomycin-C | 0.062 | 25 | 13 | 0.520 | 40.0 | 5 | 0.200 | 20.0 | 8 | 0.320 | 24.0 | 0 | 0.000 | 0.0 | |
Trend: | 0.610 | -0.192 | 0.852 | ||||||||||||
Probability: | 0.271 | 0.576 | 0.197 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Medium | 0 | 100 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
Test Chemical: | Codeine phosphate | 3000 | 100 | 4 | 0.040 | 4.0 | 0 | 0.000 | 0.0 | 4 | 0.040 | 4.0 | 0 | 0.000 | 0.0 |
Positive Control: | Mitomycin-C | 0.0025 | 100 | 15 | 0.150 | 11.0 | 4 | 0.040 | 4.0 | 7 | 0.070 | 6.0 | 4 | 0.040 | 1.0 |
Mitomycin-C | 0.0625 | 25 | 9 | 0.360 | 28.0 | 1 | 0.040 | 4.0 | 8 | 0.320 | 28.0 | 0 | 0.000 | 0.0 | |
Trend: | 0.000 | 0.000 | 0.000 | ||||||||||||
Probability: | 0.000 | 0.000 | 0.000 |